Canaccord Genuity Maintains Buy on Compass Pathways, Lowers Price Target to $48
Canaccord Genuity Maintains Buy on Compass Pathways, Lowers Price Target to $48
Canaccord Genuity維持對compass pathways的買入評級，將目標價調降至48美元。
Canaccord Genuity analyst Sumant Kulkarni maintains Compass Pathways (NASDAQ:CMPS) with a Buy and lowers the price target from $50 to $48.
Canaccord Genuity分析師Sumant Kulkarni保持對compass pathways（納斯達克代碼：CMPS）的買入評級，並將目標價從50美元下調至48美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。